Size-dependent translocation of polystyrene nanoplastics across biological barriers in mammals.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41453874.
- Also identified by DOI 10.1038/s41467-025-67876-1 and PMC identifier 12855956.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nanoplastics (NPs) pose health concerns worldwide. However, robust quantitative data on their absorption, distribution, and excretion in mammals remain scarce. Here, we provide a comprehensive assessment of polystyrene (PS) NP biodistribution and elimination in rats using <sup>14</sup>C-radiolabeling, the most accurate and quantitative method available. Pregnant rats were exposed to <sup>14</sup>C-labeled 20 nm or 100 nm PS NPs (PS<sub>20</sub> or PS<sub>100</sub>) via oral gavage, intratracheal aerosolization, or intravenous injection, and tissue distribution and excretion were determined by radioactivity measurements. We found that PS NPs were exclusively excreted through faeces, irrespective of the exposure routes, without urinary elimination. Both PS<sub>20</sub> and PS<sub>100</sub> crossed multiple biological barriers, yet only PS<sub>20</sub> reached the brain. Maternal transfer of PS<sub>20</sub> occurred through both placenta and milk, while PS<sub>100</sub> transferred solely via milk. A physiologically based toxicokinetic model further simulated accumulation kinetics across tissues. This study establishes the most comprehensive and reliable quantitative profile of PS NP biodistribution in mammals to date, revealing distinct size-dependent translocation patterns that provide a robust foundation for evaluating their health impacts.
Medical subject headings
- Polystyrenes
- Nanoparticles
- Microplastics